(1) The year ended December 31, 2023 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards ...
(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...
HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...
Core Laboratories Inc. CLB has experienced a year-to-date (“YTD”) stock price decrease of 29.7%, significantly underperforming the broader oil and gas sector and the oil and gas field services ...
Core Laboratories Inc. CLB generates revenues by providing specialized services and products to the oil and gas industry. The company offers reservoir optimization, production enhancement and ...
HOUSTON, Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of ...
Wide-moat Core Laboratories posted third-quarter results mostly in line with our estimates. Revenue of $134 million was up 3% sequentially and 7% year over year, while operating income of $20 million ...
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. US ...
Core Laboratories is in good financial health. At the last reporting period, the firm had $16 million of cash on hand and $180 million of long-term debt. 2022 net debt/adjusted EBITDA was elevated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results